ANUPKUMAR SHETTY

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology DALLAS, TX NPI 1275504136

General Payments — all program years on this page

$4,309.48

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 154
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $662.50 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $662.5021

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $188.496
2019 $192.366
2020 $496.1122
2021 $569.0527
2022 $1,361.3640
2023 $839.6132
2024 $662.5021

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087156843 Novartis Pharmaceuticals Corporation $13.33 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104296372 AstraZeneca Pharmaceuticals LP $5.11 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104414705 AstraZeneca Pharmaceuticals LP $22.45 02/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104432279 AstraZeneca Pharmaceuticals LP $29.42 05/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104548552 AstraZeneca Pharmaceuticals LP $24.12 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104594260 AstraZeneca Pharmaceuticals LP $28.21 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104777084 AstraZeneca Pharmaceuticals LP $26.15 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105203033 AstraZeneca Pharmaceuticals LP $27.74 03/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105363618 AstraZeneca Pharmaceuticals LP $21.21 06/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105577786 AstraZeneca Pharmaceuticals LP $38.21 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1111706116 Amgen Inc. $11.20 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116613546 GlaxoSmithKline, LLC. $18.29 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117381650 Amgen Inc. $121.60 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118839717 Otsuka Pharmaceutical Development & Commercialization, Inc. $23.46 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120665636 Baxter Healthcare $28.58 04/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149875137 Travere Therapeutics, Inc. $36.65 03/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149875141 Travere Therapeutics, Inc. $37.87 04/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150692094 Aurinia Pharma U.S., Inc. $27.81 07/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150692096 Aurinia Pharma U.S., Inc. $20.44 09/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154204152 Fresenius USA Marketing, Inc. $25.15 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154204154 Fresenius USA Marketing, Inc. $75.50 07/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.